10-Q: CN Healthy Food Tech Reports Strong Q3 Growth Amid Nasdaq Halt

CN Healthy Food Tech Group Corp. reported significant revenue and net income growth for Q3 and the nine months ended September 30, 2025, but faces a Nasdaq trading halt and defaults on notes payable.

Summary

• Revenue for the three months ended September 30, 2025, increased by 84.1% to $7.9 million, up from $4.3 million in the prior year period.
• Net income for the three months ended September 30, 2025, surged by 113.4% to $3.3 million, compared to $1.6 million in the prior year.
• For the nine months ended September 30, 2025, revenue grew by 278.4% to $19.9 million, from $5.3 million in the same period of 2024.
• Net income for the nine months ended September 30, 2025, increased by 265.8% to $7.0 million, up from $1.9 million in the prior year period.
• The company completed a business combination with Iron Horse Acquisition Corp. on September 29, 2025, and its common stock began trading on Nasdaq under UCFI.
• Nasdaq halted trading of the company's common stock and warrants on October 1, 2025, due to an incomplete review process by the China Securities Regulatory Commission (CSRC) regarding the U.S. listing.
• The company is in default on a $2,018,500 promissory note to an underwriter and a $1,468,690 promissory note to its Sponsor, and is negotiating maturity extensions.
• Disclosure controls and procedures were deemed ineffective as of September 30, 2025, citing issues with segregation of duties, lack of supervision and review, and limited documentation.

Sentiment

Score: 3

Explanation: While the company demonstrated impressive revenue and net income growth, the ongoing Nasdaq trading halt due to regulatory issues in China, coupled with defaults on significant debt obligations and acknowledged ineffective internal controls, creates substantial uncertainty and risk for investors. The shift to negative operating cash flow is also a concern.

Positives

• Significant revenue growth of 84.1% for the three months and 278.4% for the nine months ended September 30, 2025, driven by strategic promotional campaigns and new product launches.
• Net income more than doubled for both the three-month (113.4% increase to $3.3 million) and nine-month (265.8% increase to $7.0 million) periods.
• Strong gross profit growth, increasing by 88.8% for the quarter and 262.3% for the nine months.
• Operating income nearly doubled for the quarter (99.5% increase) and increased by 246.4% for the nine months.
• Maintained a healthy cash and cash equivalents balance of $37,207,274 and a net working capital surplus of $7,992,232 as of September 30, 2025.
• Successful completion of the business combination and listing on Nasdaq, despite the subsequent trading halt.

Negatives

• Nasdaq halted trading of common stock and warrants on October 1, 2025, due to an incomplete review by the China Securities Regulatory Commission (CSRC), which remains in effect.
• Defaulted on payment obligations for a $2,018,500 promissory note to an underwriter and a $1,468,690 promissory note to its Sponsor, requiring discussions for maturity extensions.
• Disclosure controls and procedures were assessed as "not effective" due to issues with segregation of duties, lack of supervision and review, and limited documentation.
• Cash flows from operating activities shifted from a positive $21.9 million for the nine months ended September 30, 2024, to a negative $5.7 million for the same period in 2025, primarily due to a $13.6 million decrease in advances from customers.
• High supplier concentration, with three suppliers contributing 70%, 10%, and 10% of total procurement for the three months ended September 30, 2025.

Risks

• The company's ability to meet expectations related to its products, technologies, and services, and to attract and retain revenue-generating customers and execute growth plans.
• Potential legal sanctions and penalties if the China Securities Regulatory Commission (CSRC) determines the company violates applicable Chinese securities rules and regulations.
• Inability to resume trading on the Nasdaq Capital Market since the halt on October 1, 2025, which could lead to delisting and material adverse effects on security value and liquidity.
• Failure to realize the anticipated benefits of the business combination with Iron Horse Acquisitions Corp.
• Risk of actual or alleged failure to comply with data privacy laws and regulations.
• Outcome of any legal proceedings that may be instituted against the company related to the Business Combination.
• Challenges in attracting and retaining qualified directors, officers, employees, and key personnel.
• Impact from future regulatory, judicial, and legislative changes in the company's industry.
• Risks associated with doing business in China, including complex and evolving PRC laws and regulations, regulatory approvals on offshore offerings, anti-monopoly actions, cybersecurity, and data privacy.
• Potential for Chinese regulatory authorities to disallow the holding company structure, which could materially change operations and the value of securities.
• Uncertainties with respect to the legal system and changes in laws and regulations in mainland China.
• Restrictions on the remittance of Renminbi into and out of China and governmental control of currency conversion, which may limit the ability to pay dividends and other obligations.
• The possibility of being classified as a PRC resident enterprise for tax purposes, leading to a 25% enterprise income tax rate on worldwide income.
• If the Nasdaq trading halt results in delisting, investors may face limited market quotations, reduced liquidity, potential "penny stock" designation, and decreased ability to raise additional financing.
• Potential shareholder lawsuits if Nasdaq delists the securities, incurring substantial costs and diverting management attention.
• If the wholesale distribution and live-stream sales segment revenue mix changes, operating cash flow from wholesale distribution may not be sufficient to cover operating costs, requiring additional capital.

Future Outlook

The company expects to meet its operational and capital expenditure needs for the next 12 months using existing cash and operating cash flows, but acknowledges that additional capital resources may be required due to changing business conditions or if the revenue mix between wholesale distribution and live-stream sales shifts unfavorably.

Management Comments

• "We believe our existing cash and cash equivalents will be sufficient to meet our working capital and capital expenditure needs over at least the next twelve months, though we may require additional capital resources in the future."
• "We may elect to raise additional capital through the sale of equity to fund our future needs beyond the next twelve months or through the acquisition of a debt facility."
• "The Company believes it has satisfied its obligations with respect to the CSRC and has received a legal opinion from its Chinese securities counsel to that effect."
• "Management believes that the outcome of such legal proceedings, legal actions, and claims will not have a significant adverse effect, individually, or in the aggregate, on the Company’s financial position, results of operations or cash flows."

Industry Context

The company operates in the health and wellness food industry, focusing on natural, grain-based health foods that blend modern technology with traditional Chinese medicine. The reported growth in revenue and net income suggests strong demand for its products, aligning with broader trends of increasing consumer interest in preventative health and high-quality nutritional options, particularly within the Chinese market. The reliance on wholesale distribution and live-stream sales platforms like Douyin (TikTok), Meituan, and Kuaishou indicates adaptation to modern e-commerce and social selling trends prevalent in China.

Comparison to Industry Standards

• NA The filing does not provide specific industry benchmarks or comparable companies, projects, or results to allow for a detailed assessment against global industry standards.

Management Changes

Corporate Governance

Legal Proceedings

• The company is periodically involved in legal proceedings, legal actions, and claims arising in the normal course of business, including intellectual property, safety and health, employment, and other matters. Management believes the outcome will not have a significant adverse effect.
• The company faces the risk of legal sanctions and penalties if the China Securities Regulatory Commission (CSRC) determines it violates Chinese securities rules.
• There is a risk of legal proceedings being instituted against the company related to the Business Combination.
• If Nasdaq delists the securities, the company may face shareholder lawsuits.

Related Party Transactions

• On May 30, 2024, the stockholder of Rosy Sea contributed a building (fair value $4,189,937) and a land use right (fair value $2,745,369) to the company.
• The company aggregated outstanding loan balances and a deferred business combination consideration payment of $900,000 into a single promissory note with its Sponsor for $1,421,343, which is now in default.
• The company assumed a non-interest bearing promissory note with the Sponsor totaling $47,347, which is also in default.
• On September 30, 2025, the company issued 1,000,000 shares of restricted common stock to officers of Iron Horse (Messrs. Bengochea and Caragol) for management advisory services, valued at $4,090,000.

Stakeholder Impact

• Shareholders face significant risk due to the Nasdaq trading halt, potential delisting, and the associated loss of liquidity and market value. The defaults on notes payable and internal control weaknesses also pose risks to shareholder value.
• Creditors (Underwriter, Sponsor) are impacted by the company's default on promissory notes, requiring discussions for maturity extensions.
• Employees may benefit from the growth in business operations and establishment of sales, marketing, and R&D functions, suggesting positive impact on employment opportunities.
• Customers benefit from new product launches and strategic promotional campaigns.
• Suppliers face concentration risk with a few key suppliers, which could impact the company's supply chain stability if relationships change.

Next Steps

• The company is awaiting further information from Nasdaq regarding the trading halt.
• The company is in discussions with the underwriter and Sponsor to extend the maturity dates of the defaulted promissory notes.
• The company will amortize the fair value of 1,000,000 shares issued for management advisory services over a six-month term commencing October 1, 2025.
• The company will continue to evaluate new accounting standards (ASU 2023-09, ASU 2024-03, ASU 2025-01) for their impact on financial statements and disclosures.

Key Dates

Recommendation

Despite strong reported revenue and net income growth, the company faces critical and immediate challenges that severely undermine its investment viability. The indefinite Nasdaq trading halt due to unresolved regulatory issues with the CSRC creates extreme uncertainty and liquidity risk, with a high probability of delisting. Furthermore, the company is in default on significant promissory notes to its underwriter and sponsor, indicating financial distress or mismanagement. The acknowledged "not effective" disclosure controls and procedures point to fundamental weaknesses in corporate governance and financial reporting integrity. These combined factors suggest a highly speculative and risky investment, warranting a strong sell recommendation.

Keywords

Health food, Wellness industry, China, Nasdaq listing, SEC filing, Quarterly report, Financial results, Business combination, Trading halt, Regulatory risk, Corporate governance, Wholesale distribution, Live-stream sales, UCFI